ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,182.77
-0.09%
Dow Jones
39,082.60
0.07%
US Dollar vs MXN
16.91008
-0.05%
Brent Oil
83.485
-0.09%
Bitcoin
61,083.74
-0.19%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Pharmathene, (delisted) (PIP)

  7. Pharmathene, (delisted) (PIP) Noticias

PIP

Pharmathene, (delisted) (PIP)

Pharmathene, (delisted)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:PIP
FechaHoraFuenteTítuloSímboloCompañía
01/09/201707:49Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:PIPPharmathene, (delisted)
01/09/201707:47Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:PIPPharmathene, (delisted)
28/08/201715:57Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PIPPharmathene, (delisted)
23/08/201715:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:PIPPharmathene, (delisted)
22/08/201715:50Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:PIPPharmathene, (delisted)
21/08/201716:02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:PIPPharmathene, (delisted)
21/08/201715:10Edgar (US Regulatory)Current Report Filing (8-k)AMEX:PIPPharmathene, (delisted)
18/08/201716:18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:PIPPharmathene, (delisted)
14/08/201705:08Edgar (US Regulatory)Quarterly Report (10-q)AMEX:PIPPharmathene, (delisted)
10/08/201708:59Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)AMEX:PIPPharmathene, (delisted)
20/07/201716:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:PIPPharmathene, (delisted)
15/05/201716:22Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:PIPPharmathene, (delisted)
15/05/201716:17Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)AMEX:PIPPharmathene, (delisted)
15/05/201716:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:PIPPharmathene, (delisted)
10/05/201715:13Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:PIPPharmathene, (delisted)
05/05/201712:48Edgar (US Regulatory)(25)AMEX:PIPPharmathene, (delisted)
04/05/201716:18Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)AMEX:PIPPharmathene, (delisted)
03/05/201715:57Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)AMEX:PIPPharmathene, (delisted)
03/05/201715:30PR Newswire (US)PharmAthene Reports First Quarter 2017 Financial and Operational ResultsAMEX:PIPPharmathene, (delisted)
07/04/201705:01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:PIPPharmathene, (delisted)
03/04/201715:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:PIPPharmathene, (delisted)
31/03/201713:41Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)AMEX:PIPPharmathene, (delisted)
14/03/201715:45Edgar (US Regulatory)Annual Report (10-k)AMEX:PIPPharmathene, (delisted)
14/03/201715:03PR Newswire (US)PharmAthene Reports Year-End 2016 Financial and Operational ResultsAMEX:PIPPharmathene, (delisted)
13/03/201707:03PR Newswire (US)PharmAthene Announces Record Date and Meeting Date for Special Meeting of Stockholders Regarding Proposed Merger Transaction ...AMEX:PIPPharmathene, (delisted)
08/02/201707:29InvestorsHub NewsWirePPMH Wholly-Owned Subsidiary, mPath Discovery LLC, Expands Client Base with Multiple New Channel Partnership AgreementsAMEX:PIPPharmathene, (delisted)
06/02/201705:33PR Newswire (US)Altimmune to Present at the BIO CEO & Investor ConferenceAMEX:PIPPharmathene, (delisted)
03/02/201716:27Edgar (US Regulatory)Securities Registration: Business Combination (s-4)AMEX:PIPPharmathene, (delisted)
19/01/201705:30PR Newswire (US)PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious DiseasesAMEX:PIPPharmathene, (delisted)
22/11/201616:08Edgar (US Regulatory)Amended Quarterly Report (10-q/a)AMEX:PIPPharmathene, (delisted)
 Showing the most relevant articles for your search:AMEX:PIP

Su Consulta Reciente

COIN
SOLUSD
Solana
FX
EURUSD
Euro vs US Dollar
NASDAQ
TSLA
Tesla
AMEX
SPY
SPDR S&P 500
AMEX
XLV
Health Care Select Sector
NYSE
MRK
Merck
COIN
BTCUSD
Bitcoin
NASDAQ
GOOGL
Alphabet
NYSE
MCD
McDonalds
NYSE
DIS
Walt Disney
USOTC
ADDYY
Adidas (QX)
NYSE
AXP
American Express
COIN
ETHUSD
Ethereum
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
AAPL
Apple
USOTC
DTEGY
Deutsche Telekom (QX)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados